Cleared Traditional

K810089 - 6% ORTHO LOLIUDINE REAGENT IN GLACID ACI

K810089 is the FDA 510(k) clearance for 6% ORTHO LOLIUDINE REAGENT IN GLACID ACI by Anco Medical Reagents & Assoc.. It is a Class 2 Chemistry device (product code CGE) cleared through the Traditional 510(k) pathway after a 13-day FDA review.

K810089 · Anco Medical Reagents & Assoc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1981
Decision
13d
Days
Class 2
Risk

K810089 is an FDA 510(k) clearance for the 6% ORTHO LOLIUDINE REAGENT IN GLACID ACI. Classified as Orthotoluidine, Glucose (product code CGE), Class II - Special Controls.

Submitted by Anco Medical Reagents & Assoc. (Mchenry, US). The FDA issued a Cleared decision on January 26, 1981 after a review of 13 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Anco Medical Reagents & Assoc. devices

Submission Details

510(k) Number K810089 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 13, 1981
Decision Date January 26, 1981
Days to Decision 13 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 88d · This submission: 13d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CGE Orthotoluidine, Glucose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGE Orthotoluidine, Glucose

All 7
Devices cleared under the same product code (CGE) and FDA review panel - the closest regulatory comparables to K810089.
SODIUM HYDROXIDE SOLUTION, CREATININE REAG./DILU.
K890335 · Alpkem Corp. · Feb 1989
DIRECT GLUCOSE REAGENT SET
K841054 · Medical Specialties, Inc. · May 1984
KING DIAGNOSTICS GLUCOSE-O TEST
K811883 · King Diagnostics, Inc. · Jul 1981
ORTHO-TOLUIDINE REAGENT SET
K790319 · Fisher Scientific Co., LLC · Mar 1979
GLUCOSE REAGENT (O-TOLUIDINE)
K771314 · Mallinckrodt Critical Care · Aug 1977
UNIPAK GLUCOSE
K771091 · Harleco · Jul 1977